Synergy Pharma (SGYP) Adds to Gains as Analyst Stokes Speculation Fire

September 15, 2016 11:02 AM EDT

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Synergy Pharma (NASDAQ: SGYP) is adding to recent gains after Citi highlighted the company as a biotech takeover target for Takeda yesterday. Share are up 8.5% after jumping 8.8% yesterday. Volume is running 4x normal.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Momentum Movers, Rumors, Trader Talk

Related Entities

Citi

Add Your Comment